Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Virgin Galactic Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

SPCE

  • Commercial Service Remains on Track for Q2 2023
  • Enhancements to VMS Eve and VSS Unity Complete
  • VMS Eve Has Returned to Spaceport America to Begin Flights with VSS Unity

Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic” or the "Company”) today announced its financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update.

Michael Colglazier, Chief Executive Officer of Virgin Galactic said, “It is great to see our mothership back in the skies, and we are thrilled to have VMS Eve rejoin spaceship Unity back home at Spaceport America. With our enhancement program complete and validation flights underway, we remain on track to launch commercial service in the second quarter of 2023. Our near-term objective for commercial spaceline operations is to safely deliver recurring flights with our current ships while providing an unrivaled experience for private astronauts and researchers.”

Fourth Quarter 2022 Financial Highlights

  • Cash position remains strong, with cash and cash equivalents and marketable securities of $980 million as of December 31, 2022.
  • Net loss of $151 million, compared to a $81 million net loss in the fourth quarter of 2021.
  • GAAP selling, general and administrative expenses of $47 million, compared to $38 million in the fourth quarter of 2021. Non‐GAAP selling, general and administrative expenses of $39 million in the fourth quarter of 2022, compared to $29 million in the fourth quarter of 2021.
  • GAAP research and development expenses of $103 million, compared to $40 million in the fourth quarter of 2021. Non‐GAAP research and development expenses of $99 million in the fourth quarter of 2022, compared to $36 million in the fourth quarter of 2021.
  • Adjusted EBITDA totaled $(133) million, compared to $(65) million in the fourth quarter of 2021.
  • Net cash used in operating activities totaled $131 million, compared to $65 million in the fourth quarter of 2021.
  • Cash paid for capital expenditures totaled $4 million, compared to $2 million in the fourth quarter of 2021.
  • Free cash flow totaled $(135) million, compared to $(67) million in the fourth quarter of 2021.
  • Generated $3.8 million in gross proceeds through the issuance of 0.7 million shares of common stock as part of the Company's at-the-market offering program announced on August 4, 2022.

Full Year 2022 Financial Highlights

  • Net loss of $500 million, compared to a $353 million net loss in 2021.
  • GAAP selling, general and administrative expenses of $175 million, compared to $167 million in 2021. Non-GAAP selling, general and administrative expenses of $143 million, compared to $121 million in 2021.
  • GAAP research and development expenses of $314 million, compared to $144 million in 2021. Non-GAAP research and development expenses of $300 million, compared to $129 million in 2021.
  • Adjusted EBITDA totaled $(431) million, compared to $(245) million in 2021.
  • Net cash used in operating activities totaled $380 million, compared to $231 million in 2021.
  • Cash paid for capital expenditures totaled $16 million, compared to $5 million in 2021.
  • Free cash flow totaled $(397) million, compared to $(235) million in 2021.
  • Generated $103.3 million in gross proceeds through the issuance of 16.3 million shares of common stock as part of the Company's at-the-market offering program announced on August 4, 2022.
  • Generated $425 million in gross proceeds through the issuance of convertible senior notes on January 19, 2022.

Recent Updates and Full Year Business Highlights

  • Commercial service remains on track for Q2 2023.
  • On November 2, 2022, announced Bell Textron and Qarbon Aerospace as primary suppliers to provide major subassemblies for Delta Class spaceships.
  • On August 2, 2022, announced land in New Mexico secured for a new astronaut campus and training facility.
  • On July 14, 2022, announced new final assembly manufacturing facility in Mesa, Arizona for the Delta Class spaceships.
  • On July 6, 2022, announced agreement with Aurora Flight Sciences to build the next generation motherships.

Financial Guidance

The following forward-looking statements reflect our expectations for the first quarter of 2023 as of February 28, 2023 and are subject to substantial uncertainty. Our results are based on assumptions that we believe to be reasonable as of this date, but may be materially affected by many factors, as discussed below in “Forward-Looking Statements.”

  • Forecasted free cash flow for the first quarter of 2023 is expected to be in the range of $(135) million to $(145) million.

Non-GAAP Financial Measures

In addition to the Company's results prepared in accordance with generally accepted accounting principles in the United States (GAAP), the Company is also providing certain non-GAAP financial measures. A discussion regarding the use of non-GAAP financial measures and a reconciliation of such measures to the most directly comparable GAAP information is presented later in this press release.

Conference Call Information

Virgin Galactic will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) today. To access the conference call, parties should dial +1 844 200 6205 or +1 646 904 5544 and enter the conference ID number 237767. The live audio webcast along with supplemental information will be accessible on the Company’s Investor Relations website at https://investors.virgingalactic.com/events-and-presentations/. A recording of the webcast will also be available following the conference call.

About Virgin Galactic Holdings

Virgin Galactic is an aerospace and space travel company, pioneering human spaceflight for private individuals and researchers with its advanced air and space vehicles. It is developing a spaceflight system designed to connect the world to the love, wonder and awe created by space travel and to offer customers a transformative experience. You can find more information at https://www.virgingalactic.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our spaceflight systems, expected flight schedule, timing of commercial launch, completion of our Delta class spaceship and motherships, our objectives for future operations and the Company’s financial forecasts, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the "SEC"), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.virgingalactic.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Fourth Quarter 2022 Financial Results

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except for per share amounts)

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Revenue

$

869

$

141

$

2,312

$

3,292

Operating expenses:

Customer experience

1,169

2

1,906

272

Selling, general and administrative

47,298

38,311

175,118

166,814

Research and development

102,596

40,226

314,174

144,223

Depreciation and amortization

3,117

2,883

11,098

11,518

Total operating expenses

154,180

81,422

502,296

322,827

Operating loss

(153,311

)

(81,281

)

(499,984

)

(319,535

)

Interest income

6,175

423

12,502

1,208

Interest expense

(3,206

)

(6

)

(12,130

)

(25

)

Change in fair value of warrants

(34,650

)

Other income, net

51

72

58

182

Loss before income taxes

(150,291

)

(80,792

)

(499,554

)

(352,820

)

Income tax expense

529

5

598

79

Net loss

(150,820

)

(80,797

)

(500,152

)

(352,899

)

Other comprehensive income (loss):

Foreign currency translation adjustment

167

118

(146

)

129

Unrealized gain (loss) on marketable securities

2,916

(1,566

)

(5,311

)

(2,003

)

Total comprehensive loss

$

(147,737

)

$

(82,245

)

$

(505,609

)

$

(354,773

)

Net loss per share:

Basic and diluted

$

(0.55

)

$

(0.31

)

$

(1.89

)

$

(1.43

)

Weighted-average shares outstanding:

Basic and diluted

274,902

257,888

263,947

247,619

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Balance Sheets

(In thousands)

December 31,

2022

2021

Assets

Current assets:

Cash and cash equivalents

$

302,291

$

524,481

Restricted cash

40,336

25,549

Marketable securities, short-term

606,716

79,418

Inventories

24,043

29,668

Prepaid expenses and other current assets

28,228

19,476

Total current assets

1,001,614

678,592

Marketable securities, long-term

30,392

301,463

Property, plant and equipment, net

53,658

47,498

Other non-current assets

54,274

41,281

Total assets

$

1,139,938

$

1,068,834

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable

16,326

9,237

Accrued liabilities

61,848

28,787

Customer deposits

102,647

90,863

Other current liabilities

3,232

2,636

Total current liabilities

184,053

131,523

Non-current liabilities:

Convertible senior notes, net

415,720

Other long-term liabilities

59,942

43,047

Total liabilities

659,715

174,570

Stockholders' Equity

Preferred stock

Common stock

28

26

Additional paid-in capital

2,111,316

2,019,750

Accumulated deficit

(1,623,795

)

(1,123,643

)

Accumulated other comprehensive loss

(7,326

)

(1,869

)

Total stockholders' equity

480,223

894,264

Total liabilities and stockholders' equity

$

1,139,938

$

1,068,834

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows

(In thousands)

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Cash flows from operating activities:

Net loss

$

(150,820

)

$

(80,797

)

$

(500,152

)

$

(352,899

)

Stock-based compensation

11,221

13,101

45,709

61,805

Depreciation and amortization

3,123

2,883

11,098

11,518

Amortization of debt issuance costs

532

1,998

Change in fair value of warrant liability

34,650

Other non-cash items

538

53

10,800

11

Change in operating assets and liabilities:

Inventories

(1,192

)

(363

)

5,625

815

Other current and non-current assets

(5,063

)

(9,807

)

(2,810

)

(3,465

)

Accounts payable and accrued liabilities

11,323

6,111

35,151

7,935

Customer deposits

(1,324

)

5,504

11,784

7,652

Other current and long-term liabilities

420

(1,811

)

556

1,215

Net cash used in operating activities

(131,242

)

(65,126

)

(380,241

)

(230,763

)

Cash flows from investing activities:

Capital expenditures

(4,183

)

(2,183

)

(16,489

)

(4,635

)

Purchases of marketable securities

(99,620

)

(96,752

)

(704,565

)

(382,884

)

Proceeds from maturities and calls of marketable securities

140,277

434,889

Net cash provided by (used in) investing activities

36,474

(98,935

)

(286,165

)

(387,519

)

Cash flows from financing activities:

Payments of finance lease obligations

(102

)

(35

)

(234

)

(140

)

Proceeds from convertible senior notes

425,000

Debt issuance costs

(11,278

)

Purchase of capped call

(52,318

)

Repayment of commercial loan

(310

)

(310

)

Proceeds from issuance of common stock

3,753

103,326

500,000

Proceeds from issuance of common stock pursuant to stock options exercised

1,124

49

19,980

Withholding taxes paid on behalf of employees on net settled stock-based awards

(505

)

(7,622

)

(3,984

)

(23,401

)

Transaction costs related to issuance of common stock

(111

)

(19

)

(1,248

)

(6,772

)

Net cash provided by (used in) financing activities

3,035

(6,552

)

459,003

489,357

Net decrease in cash, cash equivalents and restricted cash

(91,733

)

(170,613

)

(207,403

)

(128,925

)

Cash, cash equivalents and restricted cash at beginning of period

434,360

720,643

550,030

678,955

Cash, cash equivalents and restricted cash at end of period

$

342,627

$

550,030

$

342,627

$

550,030

Cash and cash equivalents

$

302,291

$

524,481

$

302,291

$

524,481

Restricted cash

40,336

25,549

40,336

25,549

Cash, cash equivalents and restricted cash

$

342,627

$

550,030

$

342,627

$

550,030

USE OF NON-GAAP FINANCIAL MEASURES

This press release references certain financial measures that are not prepared in accordance with generally accepted accounting principles in the United States (GAAP), including Adjusted EBITDA, non-GAAP selling, general and administrative expenses, non-GAAP research and development expenses and free cash flow. The Company defines Adjusted EBITDA as earnings before interest expense, income taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. It defines non-GAAP selling, general and administrative expenses as selling, general and administrative expenses other than stock-based compensation and non-GAAP research and development expenses as research and development expenses other than stock-based compensation. It defines free cash flow as net cash provided by operating activities less capital expenditures. None of these non-GAAP financial measures is a substitute for or superior to measures prepared in accordance with GAAP and should not be considered as an alternative to any other measures derived in accordance with GAAP.

The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.

A reconciliation of net loss to Adjusted EBITDA for the three months ended December 31, 2022 and 2021 and years ended December 31, 2022 and 2021, respectively, is set forth below (in thousands):

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Net loss

$

(150,820

)

$

(80,797

)

$

(500,152

)

$

(352,899

)

Income tax expense

529

5

598

79

Interest expense

3,206

6

12,130

25

Depreciation and amortization

3,117

2,883

11,098

11,518

EBITDA

(143,968

)

(77,903

)

(476,326

)

(341,277

)

Stock-based compensation

11,221

13,101

45,709

61,805

Change in fair value of warrants

34,650

Adjusted EBITDA

$

(132,747

)

$

(64,802

)

$

(430,617

)

$

(244,822

)

A reconciliation of selling, general and administrative expenses to non-GAAP selling, general and administrative expenses for the three months ended December 31, 2022 and 2021 and years ended December 31, 2022 and 2021, respectively, is set forth below (in thousands):

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Selling, general and administrative expenses

$

47,298

$

38,311

$

175,118

$

166,814

Stock-based compensation

7,887

9,177

31,955

46,181

Non-GAAP selling, general

and administrative expenses

$

39,411

$

29,134

$

143,163

$

120,633

A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended December 31, 2022 and 2021 and years ended December 31, 2022 and 2021, respectively, are set forth below (in thousands):

Three Months Ended

Year Ended

December 31,

December 31,

2022

2021

2022

2021

Research and development expenses

$

102,596

$

40,226

$

314,174

$

144,223

Stock-based compensation

3,334

3,924

13,754

15,624

Non-GAAP research and

development expenses

$

99,262

$

36,302

$

300,420

$

128,599

The following table reconciles forecasted net cash used in operating activities to forecasted free cash flow for the three months ending March 31, 2023 (in thousands):

Forecasted Range

Net cash used in operating activities

$(127,000)-$(133,000)

Capital expenditures

$(8,000)-$(12,000)

Free cash flow

$(135,000)-$(145,000)

_______________



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today